Navigating the gene & cell therapy regulatory landscape: when, why and how to deploy GMP gene editing materials

Cell and Gene Therapy Insights 2023; 9(4), 521;


Published: 13 June 2023
Michael Lau

Watch the video or view the poster to learn more about:

  • When and why you should transition from RUO to cGMP gene editing materials for gene & cell therapy development
  • Why phase-appropriate gene editing materials (sgRNA, Cas9, DNA insert templates) are key in supporting gene & cell therapy development
  • How to avoid long production delays with cGMP materials